PMID- 17625110 OWN - NLM STAT- MEDLINE DCOM- 20071113 LR - 20220317 IS - 0006-3363 (Print) IS - 0006-3363 (Linking) VI - 77 IP - 4 DP - 2007 Oct TI - Promoter methylation regulates estrogen receptor 2 in human endometrium and endometriosis. PG - 681-7 AB - Steroid receptors in the stromal cells of endometrium and its disease counterpart tissue endometriosis play critical physiologic roles. We found that mRNA and protein levels of estrogen receptor 2 (ESR2) were strikingly higher, whereas levels of estrogen receptor 1 (ESR1), total progesterone receptor (PGR), and progesterone receptor B (PGR B) were significantly lower in endometriotic versus endometrial stromal cells. Because ESR2 displayed the most striking levels of differential expression between endometriotic and endometrial cells, and the mechanisms for this difference are unknown, we tested the hypothesis that alteration in DNA methylation is a mechanism responsible for severely increased ESR2 mRNA levels in endometriotic cells. We identified a CpG island occupying the promoter region (-197/+359) of the ESR2 gene. Bisulfite sequencing of this region showed significantly higher methylation in primary endometrial cells (n = 8 subjects) versus endometriotic cells (n = 8 subjects). The demethylating agent 5-aza-2'-deoxycytidine significantly increased ESR2 mRNA levels in endometrial cells. Mechanistically, we employed serial deletion mutants of the ESR2 promoter fused to the luciferase reporter gene and transiently transfected into both endometriotic and endometrial cells. We demonstrated that the critical region (-197/+372) that confers promoter activity also bears the CpG island, and the activity of the ESR2 promoter was strongly inactivated by in vitro methylation. Taken together, methylation of a CpG island at the ESR2 promoter region is a primary mechanism responsible for differential expression of ESR2 in endometriosis and endometrium. These findings may be applied to a number of areas ranging from diagnosis to the treatment of endometriosis. FAU - Xue, Qing AU - Xue Q AD - Division of Reproductive Biology Research, Department of Obsterics and Gynecology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, USA. FAU - Lin, Zhihong AU - Lin Z FAU - Cheng, You-Hong AU - Cheng YH FAU - Huang, Chiang-Ching AU - Huang CC FAU - Marsh, Erica AU - Marsh E FAU - Yin, Ping AU - Yin P FAU - Milad, Magdy P AU - Milad MP FAU - Confino, Edmond AU - Confino E FAU - Reierstad, Scott AU - Reierstad S FAU - Innes, Joy AU - Innes J FAU - Bulun, Serdar E AU - Bulun SE LA - eng GR - U54-HD40093/HD/NICHD NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20070711 PL - United States TA - Biol Reprod JT - Biology of reproduction JID - 0207224 RN - 0 (ESR1 protein, human) RN - 0 (Estrogen Receptor alpha) RN - 0 (Estrogen Receptor beta) RN - 0 (RNA, Messenger) RN - 0 (Receptors, Progesterone) RN - 0 (progesterone receptor B) RN - 776B62CQ27 (Decitabine) RN - M801H13NRU (Azacitidine) SB - IM MH - Adult MH - Azacitidine/analogs & derivatives/pharmacology MH - Cells, Cultured MH - CpG Islands MH - *DNA Methylation MH - Decitabine MH - Endometriosis/*genetics MH - Endometrium/drug effects/*metabolism MH - Estrogen Receptor alpha/genetics MH - Estrogen Receptor beta/*genetics MH - Female MH - Gene Expression Regulation/*genetics MH - Humans MH - Promoter Regions, Genetic/drug effects MH - RNA, Messenger/analysis/metabolism MH - Receptors, Progesterone/genetics MH - Stromal Cells/drug effects/metabolism EDAT- 2007/07/13 09:00 MHDA- 2007/11/14 09:00 CRDT- 2007/07/13 09:00 PHST- 2007/07/13 09:00 [pubmed] PHST- 2007/11/14 09:00 [medline] PHST- 2007/07/13 09:00 [entrez] AID - biolreprod.107.061804 [pii] AID - 10.1095/biolreprod.107.061804 [doi] PST - ppublish SO - Biol Reprod. 2007 Oct;77(4):681-7. doi: 10.1095/biolreprod.107.061804. Epub 2007 Jul 11.